Sun Yat-sen University

NCT07824856

Phase 2Not yet recruiting2026138 people17 Sept 2026clinicaltrials.gov

NCT07809893

Phase 2Recruiting202645 people9 Sept 2026clinicaltrials.gov

NCT07753642

Phase 2Not yet recruiting202647 people7 Aug 2026clinicaltrials.gov

NCT07729592

Phase 2Not yet recruiting202644 people27 Jul 2026clinicaltrials.gov

NCT07646301

Phase 2Recruiting2026103 people12 Jun 2026clinicaltrials.gov

NCT07540390

Phase 3Not yet recruiting2026442 people20 Apr 2026clinicaltrials.gov

NCT07524413

Phase 3Not yet recruiting2026514 people13 Apr 2026clinicaltrials.gov

NCT07385079

Phase 3Not yet recruiting2026412 people3 Feb 2026clinicaltrials.gov

NCT07373990

Phase 3Not yet recruiting2026418 people28 Jan 2026clinicaltrials.gov

NCT07371897

Phase 3Not yet recruiting2026154 people28 Jan 2026clinicaltrials.gov

NCT07238569

Phase 3Not yet recruiting2025516 people20 Nov 2025clinicaltrials.gov

NCT07201337

Phase 3Active, not recruiting2025700 people1 Oct 2025clinicaltrials.gov

NCT07145931

Phase 2Not yet recruiting202524 people28 Aug 2025clinicaltrials.gov

NCT07138989

Phase 2Not yet recruiting202510 people24 Aug 2025clinicaltrials.gov

NCT07129772

CollaboratorPhase 2Not yet recruiting202553 people19 Aug 2025clinicaltrials.gov

NCT07125755

Phase 3Recruiting2025386 people15 Aug 2025clinicaltrials.gov

NCT07110558

Phase 2Not yet recruiting202559 people7 Aug 2025clinicaltrials.gov

NCT07008716

Phase 3Recruiting2025852 people6 Jun 2025clinicaltrials.gov

NCT06903858

Phase 2Recruiting2025105 people1 Apr 2025clinicaltrials.gov

NCT06900647

Phase 1Recruiting202520 people28 Mar 2025clinicaltrials.gov

Senescence-associated prostate cancer cells promote fibroblast reprogramming and extracellular matrix remodeling

ZSQYRSFPD01141 Oct 2026api.crossref.org